Sitemap
June 04, 2018 Articles
Filter by Available Specialty
- ‘Imposter syndrome’ prevalent among women in medicine, but can be overcome
- Abortion may not negatively impact women’s mental health
- Adjuvant FOLFIRINOX new standard of care for pancreatic cancer
- Agent ISR: Coronary DCBs similar for treatment of in-stent restenosis
- AHA: Health literacy critical in CVD prevention
- AOA voices concerns over quality of new optometry schools
- Benefit of chromoendoscopy requires more evidence, expert says
- BLOG: Nontraditional primary care
- Childhood hyperthyroidism may be on the rise
- COMPASS: Low-dose rivaroxaban plus aspirin may benefit patients with chronic CAD, PAD, HF
- EMPA-REG Outcome: Empagliflozin reduces kidney events in HF
- Endostim safe, effective for certain patients with persistent GERD symptoms
- Epithelium remodels after accelerated cross-linking
- Erdafitinib shows promise for metastatic urothelial carcinoma
- Expert highlights gut microbiome studies from DDW 2018
- FDA approves Fulphila, first Neulasta biosimilar, to prevent infection during cancer treatment
- FDA commissioner: Greater efficiencies can unlock opportunities created by better science
- FDA issues alert after deaths associated with intragastric balloons
- First patient enrolled in enVista MX60EF trifocal IOL trial
- First-line pembrolizumab improves survival for PD-L1-positive non-small cell lung cancer
- Hemangeol found to be safe in treating infantile hemangioma
- IL-15 inhibitor shows promise in halting progression of refractory celiac disease type II
- Itopride shows promise in functional dyspepsia
- Joint depression aided prediction of bucket-handle meniscal tears after tibial plateau fracture
- Left unchecked, global warming may shape future epidemics
- Lisocabtagene maraleucel shows promise for pretreated non-Hodgkin lymphoma
- Medical therapy ‘reasonable option’ vs. surgery in Cushing’s disease
- Mediterranean diet lowers risk for air pollution-related complications, CVD death
- Metformin safe in patients with mild, moderate chronic kidney disease
- Mobile intervention as effective as clinic-based approach for serious mental illness
- Mount Sinai Health System to use artificial intelligence to track patients at risk for chronic kidney disease
- Moxetumomab pasudotox shows promise in relapsed, refractory hairy cell leukemia
- Nearly 40% of patients fail to initiate prescribed RA treatment
- Neoadjuvant androgen deprivation therapy with enzalutamide active in high-risk localized prostate cancer
- New Canadian guideline expands HCV screening to baby boomers
- New method improves CVD risk prediction
- Nivolumab shows durable benefit for advanced melanoma
- No new adverse events related to DTaP vaccines reported
- Northwest Kidney Centers hires vice president of patient care services, chief nursing officer
- Peptilogics receives qualified infection disease product designation for PJI treatment
- Peripheral DES effective in real-world cohort, with caveat
- Personalized IBD care program reduces hospitalization, improves BMI
- Portal hypertension predicts variceal hemorrhage in biliary atresia
- Regeneron reports $478 million in first quarter income
- Relapse after LT for alcoholic liver disease more common in younger patients
- Ribociclib plus fulvestrant improves PFS for advanced breast cancer
- Sandoz obtains positive CHMP opinion for Humira biosimilar
- Tear Film completes Series B funding
- TearLab posts quarterly net loss
- Top stories in cardiology: protein intake increases heart failure risk, vitamins provide minimal cardiovascular benefit
- Treatment failure in children with asthma linked to influenza
- Undiagnosed celiac disease more common in women
- Use of heated chemotherapy during surgery does not improve colorectal cancer survival
- VIDEO: Presenter speaks about extreme swimming injuries
- VIDEO: Vidal discusses management of articular cartilage injuries in extreme sports
- Yoga reduces frequency of urinary incontinence